A randomised phase I study of etrolizumab (rhuMAb ß7) in moderate to severe ulcerative colitis.
Rutgeerts, Paul J.; Fedorak, Richard N.; Hommes, Daan W.; Sturm, Andreas; Baumgart, Daniel C.; Bressler, Brian; Schreiber, Stefan; Mansfield, John C.; Williams, Mama; Tang, Meina; Visich, Jennifer; Xiaohui Wei; Keir, Mary; Luca, Diana; Danilenko, Dimitri; Egen, Jackson; O'Byrne, Sharon; Gut, 2013, vol. 62, issue 8, p 1122, ISSN 00175749. ISBN 14683288.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef